Ambulatory blood pressure parameters in antihypertensive drug-naïve subjects with prediabetes

Authors

DOI:

https://doi.org/10.2478/AMB-2025-0053

Keywords:

prediabetes, hypertension, ambulatory blood pressure monitoring, non-dippers

Abstract

The aim of this study was to evaluate ambulatory blood pressure characteristics in subjects with prediabetes who have not been treated with antihypertensive drugs. The assessment was not only targeting undiagnosed hypertension but also the “white-coat” hypertension (WCH), masked hypertension (MaskH) and abnormal circadian blood pressure patterns (non-dippers, extreme dippers). One hundred and twenty subjects (56 males, 64 females), of mean age 44.72 ± 12.49 years, were included in the study. After evaluation of glucose tolerance the participants were divided into two groups: Group 1 – subjects with prediabetes; and Group 2 (Control group) – subjects with normal glucose tolerance (NormGT). All participants were without previously diagnosed hypertension and had never received any antihypertensive drug. Standard anthropometric parameters – weight, height and waist circumference, were measured in all subjects. Blood pressure was measured by ambulatory blood pressure monitoring. No significant differences in the anthropometric parameters have been observed. The ambulatory blood pressure monitoring identified higher prevalence of undiagnosed hypertension among the subjects with prediabetes (52.17% vs 43.24% in the control group). The prevalence of masked hypertension was lower among the subjects with prediabetes (13.33%), compared to NormGT (28.88%). For WCH the prevalence in prediabetes (27.27%) was slightly lower than in the control group (34.48%). The analysis of the circadian pattern of ambulatory blood pressure demonstrated higher prevalence of “non-dippers” in the group with prediabetes (36.96% vs 28.38%), while the prevalence of “extreme dippers” was close to that of the control group (8.69% vs 9.46%). The high prevalence of undiagnosed hypertension among subjects with prediabetes suggests that ambulatory blood pressure monitoring could be used on a regular basis in the evaluation of subjects with prediabetes considered normotensive. The method could also be important to identify “non-dippers” as the prevalence of this pattern tends to be higher in prediabetes.

References

Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19(9):708-23.

American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40 (Suppl. 1):S1-S135.

Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003; 26(3):868-74.

Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006; 29(8):1909-14.

McMaster University Evidence Based Practice Center. Diagnosis, prognosis and treatment of impaired glucose tolerance and impaired fasting glucose. Evidence Report 128. 2005.

Chakarova N. Cardiovascular risk in prediabetic conditions – impaired fasting glucose and impaired glucose tolerance [in Bulgarian] Dissertation, 2011, Sofia.

World Health Organization. Defi nition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Geneva, WHO, 2006.

Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104.

Festa A, D’Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004; 53(6):1549-55.

Nabila S, Kim JE, Choi J, et al. Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes. Diabetes Care. 2023; 46(3):535-543. doi: 10.2337/dc22-1042.

Li Z, Kang S, Kang H. Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes. Sci Rep. 2024; 14(1):20909. doi: 10.1038/s41598-024-71904-3.

Ishikawa J, Schwartz JE, Pickering TG. Pre-diabetes is Associated with Masked Hypertension. Circulation. 2009; 120:S1060.

Geijerstam PA, Engvall J, Östgren CJ, et al. Home Blood Pressure Compared with Office Blood Pressure in Relation to Dysglycemia. Am J Hypertens. 2022; 35(9):810-819.

Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in „white coat hypertension“ and „masked hypertension“. Am J Hypertens 2008; 21: 393-399.

Hänninen MR, Niiranen TJ, Puukka PJ, et al. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 10: 1880-1888.

Gupta AK, Greenway FL, Cornelissen G, et al. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 2008; 22(9):627-33.

Jug J, Delalić Đ, Bralić Lang V, et al. Prediabetes, Non-Dipping Profile and Hypertension-A Recipe for Increased Arterial Stiffness. Biomedicines. 2023; 11(4):1065. doi: 10.3390/biomedicines11041065.

Obayashi K, Saeki K, Kurumatani N. Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study. Clin J Am Soc Nephrol. 2016; 11(5):867-74.

Kwon BJ, Kim DW, Park MW, et al. Clinical implications of combined glucose intolerance in treatment-naïve hypertensive patients. Clin Exp Hypertens. 2018; 40(8):762-771.

Downloads

Published

02.09.2025

Issue

Section

ORIGINAL ARTICLES

How to Cite

Stoynev, N., & Tankova, T. (2025). Ambulatory blood pressure parameters in antihypertensive drug-naïve subjects with prediabetes. Acta Medica Bulgarica, 52(3), 1-6. https://doi.org/10.2478/AMB-2025-0053